You are here

Protecting your herd from disease takes more than just the vaccination

Correct handling and administration are key to maintaining vaccination effectiveness.
St. Joseph, Missouri, August 16, 2012 — As beef producers move into the fall working season, it is important to keep in mind management practices to protect against disease challenges. 
Properly vaccinating calves is one management practice that can help calves be healthier, avoid financial losses down the road and provide the best possible product to the consumer.
However, simply vaccinating your calves is not enough. Correct storage, handling and administration practices must be followed in order to ensure the effectiveness of the vaccination.
“As we consider vaccinating the calves, either pre-weaning or at weaning time, it is pretty universally accepted that protecting against respiratory disease, rather than treating disease, is far better for the animal, the producer and even for our consumer,” says Dr. Jerry Woodruff, Professional Services Veterinarian for Boehringer Ingelheim Vetmedica, Inc.
Boehringer Ingelheim Vetmedica, Inc. recommends adhering to the following five keys to handling and using cattle vaccines to receive full benefit from vaccinations:
• Store vaccines in accordance with labeling, generally 35°F to 45°F. Follow label directions.
• Protect vaccines and filled syringes from sunlight and heat.
• Use modified-live virus (MLV) vaccines within an hour of mixing.
• Discard bent or broken needles. Change needles often (about every ten animals).
• Clean syringes with hot distilled water (212 degrees F). Use care not to burn your skin with hot water. Do not use soap or disinfectant.
Making sure vaccines are never frozen is key, says Dr. Woodruff, as freezing temperatures will cause damage. Exposure to sunlight and heat will have similar effects on the vaccines. For modified-live virus vaccines, make sure to use them within one hour after mixing, as viability of the vaccine declines after mixing.
Changing needles every ten head is also critical, not only to ensure cleanliness, but to avoid unnecessary tissue damage to the animal.
“A burred or blunted end of the needle is likely to cause damage to the skin and underlying tissue,” says Dr. Woodruff.
 “Unnecessary tissue damage can lead to injection site lesions and possible backflow of vaccine at the injection site, both of which can lower the probability that the animal is adequately protected from disease.”
Following the five keys to handling and using cattle vaccines helps producers ensure that the vaccinations they administer more effectively protect their animals throughout their lifetime.
“It is very important that producers understand that these vaccine products are relatively inexpensive compared to the value of the animal,” says Dr. Woodruff. “It is imperative that we handle the vaccines properly, we administer them with the best technique possible, such that we can achieve the kind of response from those vaccines to reduce disease.”
Vaccines and their correct handling are an integral part of Boehringer Ingelheim Vetmedica, Inc. and its Prevention Works platform.
To develop a vaccination plan that works best for you, work with your local veterinarian.  For more information on Prevention Works, please visit, www.BIVIPreventionWorks.com, or talk with your local Boehringer Ingelheim Vetmedica, Inc. representative.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, MO) is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT, and a member of the Boehringer Ingelheim group of companies. 
 





For more information, 
please contact:
Rene Ward

Associate Director, Public Relations and Internal Communications 

(816) 236-8276 
Wayne Cole

Senior Brand Manager 
(816) 236-2763

ABOUT BOEHRINGER INGELHEIM

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.


As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the
foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.


In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.


For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.
©2012 Boehringer Ingelheim Vetmedica, Inc.  
Boehringer Ingelheim Vetmedica, Inc
2621 N. Belt Highway
St. Joseph, MO 64506
US
Read the VerticalResponse marketing policy.
Read more about